Serrapeptase

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Serrapeptase is a protease indicated in the treatment of post-surgical inflammation.

Generic Name
Serrapeptase
DrugBank Accession Number
DB13131
Background

Serrapeptase is a proteolytic enzyme preparation used concomitantly with an antibiotic in osteoarticular infections. Serratiopeptidase is under investigation in clinical trial NCT02493179 (Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery).

Type
Biotech
Groups
Investigational
Biologic Classification
Protein Based Therapies
Other protein based therapies
Protein Chemical Formula
Not Available
Protein Average Weight
Not Available
Sequences
Not Available
Synonyms
  • Serrapeptase
  • Serratiopeptidase

Pharmacology

Indication

Not Available

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Danzen TabletsTabletOralLUEN WAH MEDICAL CO. SDN. BHD.2020-09-08Not applicableMalaysia flag
DENZO TABLET 5MGTabletOralDYNAPHARM (M) SDN BHD2020-09-08Not applicableMalaysia flag
Enzdase E.C. Tablets 5mgTabletOralKIREEN PHARMACEUTICAL SDN. BHD.2020-09-08Not applicableMalaysia flag
PEPZEN TABLET 5MGTabletOralPRIME PHARMACEUTICAL SDN. BHD.2020-09-08Not applicableMalaysia flag
Serrata Tablets 10mgTablet, coatedOralPAHANG PHARMACY SDN. BHD.2020-09-08Not applicableMalaysia flag
SERRIN TABLETTabletOralHEALOL PHARMACEUTICALS SDN. BHD.2020-09-08Not applicableMalaysia flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
Not Available
Kingdom
Organic Compounds
Super Class
Organic Acids
Class
Carboxylic Acids and Derivatives
Sub Class
Amino Acids, Peptides, and Analogues
Direct Parent
Peptides
Alternative Parents
Not Available
Substituents
Not Available
Molecular Framework
Not Available
External Descriptors
Not Available
Affected organisms
Not Available

Chemical Identifiers

UNII
NL053ABE4J
CAS number
95077-02-4

References

General References
  1. FDA Thailand Product Information: Sumidin (serrapeptase) oral tablets [Link]
  2. NPRA: Serrata (Serrapeptase) Oral Tablet [Link]
PubChem Substance
347911427
RxNav
36434
Wikipedia
Serratiopeptidase

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Unknown StatusTreatmentInflammation / Swelling / Trismus1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Tablet, delayed releaseOral5 mg
TabletOral
Tablet, coatedOral5 mg
Tablet, coatedOral10 mg
Tablet, coatedOral
Tablet, delayed releaseOral10 mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on October 21, 2016 03:33 / Updated on June 12, 2021 10:55